Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 3,926–3,950 of 7,816 matching trials · page 158 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
PST for Care Partners of Adults With Alzheimer's and Alzheimer'S-related Dementia NCT04748666 Problem Solving Training Runs in: United States · 3 sites |
NA other |
COMPLETED | 94 | University of Texas Southwestern Medical Center OTHER |
2023-08-01 |
|
Hypnosis for Sleep Quality in Caregivers of Individuals With Alzheimer's Disease NCT04779866 Self-Administered Hypnosis; Self-Administered White Noise Hypnosis Runs in: United States · 1 site |
NA other |
COMPLETED | 20 | Baylor University OTHER |
2023-08-01 |
|
Sensory Room at an Acute Psychiatric Unit NCT05512858 sensory room Runs in: Israel · 1 site |
NA other |
COMPLETED | 80 | Tel Aviv University OTHER |
2023-08-01 |
|
Computerized Cognitive Training for Diabetic Elderly Veterans NCT01736124 computerized cognitive training; control games Runs in: United States · 1 site |
PHASE4 other |
COMPLETED | 199 | VA Office of Research and Development OTHER_GOV |
2023-07-27 |
|
Delivery Models of Caregiver Support and Education NCT02368132 Group Delivered TEP; Individual Delivered TEP Runs in: United States · 2 sites |
NA other |
COMPLETED | 319 | VA Office of Research and Development OTHER_GOV |
2023-07-27 |
|
Feasibility of Gamma Transcranial Alternating Current Stimulation to Reduce Beta-amyloid Load and Improve Memory NCT04646499 Transcranial alternating current stimulation Runs in: United States · 1 site |
NA other |
COMPLETED | 14 | University of California, San Francisco OTHER |
2023-07-27 |
|
Long Term Transcranial Pulse Stimulation (TPS) on Older Adults With Mild Neurocognitive Disorder (NCD) NCT05602467 Transcranial Pulse Stimulation (TPS); Treatment as usual (TAU) Runs in: Hong Kong · 1 site |
NA other |
UNKNOWN | 22 | The University of Hong Kong OTHER |
2023-07-27 |
|
DIGITAL Biomarker: Blood Based Biomarkers in the Primary Care Setting for Alzheimer's Disease NCT05844488 PrecivityAD Runs in: United States · 1 site |
NA other |
COMPLETED | 26 | Indiana University OTHER |
2023-07-25 |
|
Post-marketing Surveillance of Donepezil Hydrochloride -Investigation of the Clinical Safety and Effectiveness in Patients With Alzheimer's Disease NCT01251718 donepezil hydrochloride Runs in: Japan · 106 sites |
NA symptomatic-cholinergic |
COMPLETED | 894 | Eisai Co., Ltd. INDUSTRY |
2023-07-24 |
|
Combined Aerobic Exercise and Cognitive Training in Seniors at Increased Risk for Alzheimer's Disease NCT05163626 Combined aerobic exercise and cognitive training program Runs in: China · 1 site |
NA other |
NOT_YET_RECRUITING | 200 | Xuanwu Hospital, Beijing OTHER |
2023-07-24 |
|
Safety, Tolerability and Activity of SRX246 in Adults With Intermittent Explosive Disorder NCT02055638 SRX246; Placebo Runs in: United States · 7 sites |
PHASE1|PHASE2 other |
COMPLETED | 97 | Azevan Pharmaceuticals INDUSTRY |
2023-07-21 |
|
Combined Aerobic Exercise and Cognitive Training in Seniors With Genetic Susceptibility for Alzheimer's Disease NCT05163067 Combined aerobic exercise and cognitive training program Runs in: China · 1 site |
NA other |
NOT_YET_RECRUITING | 200 | Xuanwu Hospital, Beijing OTHER |
2023-07-21 |
|
Study to Assess the Absorption, Metabolism, Excretion, and Mass Balance of CT1812 in Healthy Adult Male Subjects NCT05225389 300 mg [C14] CT1812 Runs in: United States · 1 site |
PHASE1 other |
COMPLETED | 8 | Cognition Therapeutics INDUSTRY |
2023-07-21 |
|
Adapting Connect-Home Transitional Care for the Unique Needs of Persons With Alzheimer's Disease and Other Dementias and Their Caregivers NCT05887388 Connect-Home Plus Runs in: United States · 1 site |
NA other |
COMPLETED | 38 | University of North Carolina, Chapel Hill OTHER |
2023-07-21 |
|
Tolerability, Safety, and Activity of SRX246 in Irritable Subjects With Huntington's Disease NCT02507284 SRX246; Placebo Runs in: United States · 22 sites |
PHASE2 other |
COMPLETED | 106 | Azevan Pharmaceuticals INDUSTRY |
2023-07-20 |
|
Managing Pain and Cognitions in Older Adults With Mild Cognitive Impairment or Memory Related Problems and Chronic Pain NCT04044183 Active Brains 1; Active Brains 2 Runs in: United States · 1 site |
NA other |
COMPLETED | 21 | Massachusetts General Hospital OTHER |
2023-07-20 |
|
A Scalable Model for Promoting Functioning and Well-Being Among Older Adults With Mild Cognitive Impairment Via Meaningful Social Interactions: Project SPEAK! NCT04717479 Intervention (videoconferencing) Runs in: United States · 1 site |
NA other |
COMPLETED | 80 | University of Michigan OTHER |
2023-07-20 |
|
The INCREASE Study - Delaying the Onset of Alzheimer's Symptomatic Expression NCT02849639 Placebo; Medication Therapy Management (MTM); Scopolamine patch Runs in: United States · 1 site |
EARLY_PHASE1 other |
COMPLETED | 90 | Daniela Moga OTHER |
2023-07-19 |
|
Telephone-delivered Mindfulness Intervention for African American Dementia Caregivers NCT04058886 Telephone-delivered Mindfulness Runs in: United States · 1 site |
NA other |
COMPLETED | 57 | University of North Carolina, Chapel Hill OTHER |
2023-07-19 |
|
COG-REAGENT: COGnitive tRaining in patiEnts With Amnestic Mild coGnitive impairmENT NCT04063956 multi-domain internet-based adaptive training program; active-contr... Runs in: China · 1 site |
NA other |
UNKNOWN | 260 | Xuanwu Hospital, Beijing OTHER |
2023-07-19 |
|
A Study to Evaluate the Safety, Tolerability, and Blood Levels of ACU193 in Participants With MCI or Mild AD NCT04931459 ACU193; Placebo Runs in: United States · 17 sites |
PHASE1 other |
COMPLETED | 65 | Acumen Pharmaceuticals INDUSTRY |
2023-07-19 |
|
Continuation of The Kronos Early Estrogen Prevention Study (KEEPS) NCT03718494 Brain Magnetic Resonance Imaging (MRI); F-18 Florbetapir Positron E... Runs in: United States · 6 sites |
NA other |
COMPLETED | 299 | Mayo Clinic OTHER |
2023-07-17 |
|
Aggression From the Perspective of Patients and Nurses NCT05946720 Training including aggression and the use of BVC. Runs in: Turkey (Türkiye) · 1 site |
NA other |
COMPLETED | 97 | Muğla Sıtkı Koçman University OTHER |
2023-07-14 |
|
Dose-Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of Donepezil From Single Dose of GB-5001 IM Depot and Aricept® Oral Tablets in Healthy Male Volunteers NCT05525780 GB-5001; Placebo; Oral cohort Runs in: Canada · 1 site |
PHASE1 symptomatic-cholinergic |
COMPLETED | 48 | G2GBio, Inc. INDUSTRY |
2023-07-13 |
|
Dementias and Microbiota Composition: Is Possible to Revert the Dementia Symptoms Reverting the Microbiota Composition? NCT05943925 No intervention; Probiotic supplement Runs in: Spain · 1 site |
NA other |
UNKNOWN | 240 | University Rovira i Virgili OTHER |
2023-07-13 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial